Company profile
Andersen Pharmaceutical company profile
Andersen Pharmaceutical engages in pharmaceutical R&D, production, and sales. Its research project "National Class 1.1 Anti-tumor Chemical New Drug Taxideptide" has been supported by the Ministry of Science and Technology and the National Health and Family Planning Commission's "Major New Drug Creation" National Major Project (Project No.: 2015ZX09101002), and was approved by the Standing Committee of the 11th National People's Congress. Chairman Huisang Guowei identified it as one of the two innovative drugs to be developed during the country's 13th Five-Year Plan period. In the 4th China Innovation and Entrepreneurship Competition, Anderson Pharmaceuticals stood out among more than 700 enterprises..... For more information, log in to dureach.com to view the full company profile.
Business identity
- Operating status
- Active
- Company type
- For Profit
- Founded
- 2009-01-01
Headquarters
- Headquarters
- Anhui, China, Hefei
- Country code
- CN
- Continent
- Asia